Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074237 · ClinicalTrials.gov registry record · NA

Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters

A NA study of Vaccine Refusal and Physician-Patient Relations, sponsored by Corewell Health East.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT06074237 is a NA study of Vaccine Refusal and Physician-Patient Relations that has completed, run by Corewell Health East. The registered enrollment target is 112 participants, below the 1,295-participant average among 5 other Vaccine Refusal trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074237, a NA study of Vaccine Refusal and Physician-Patient Relations, has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

Unfortunately, only 40% of US pediatric residency programs reported in a survey that vaccine safety and counseling training is provided to residents. The success of a residency curriculum focused on communication strategies with patients hesitant to receive the influenza vaccine has been demonstrated, finding a decreased rate of vaccination refusal in the post curricular period. In a recent 2020 study, it demonstrated the positive impact of an online vaccine curriculum on resident vaccine knowledge and self-reported confidence in counseling vaccine hesitant patients. Providers have the potential to impact a substantial pediatric patient population. The outpatient clinics where the residents included in this study care for patients had 9942 pediatric visits in 2021. Each visit is an opportunity to talk with families about vaccines, address concerns and to administer vaccines when needed. The hypothesize is that interactive educational interventions using the online training modules combined with the standardized patient encounters will increase resident vaccine knowledge and confidence, and enhance communication and counseling skills, thereby improving vaccination rates of Human Papilloma Virus (HPV), Influenza, Measles/Mumps/Rubella (MMR) and Coronavirus (COVID-19) in the Beaumont residency clinics.

Interventions

  • OTHER Immersive resident education
  • OTHER Standardized patient (SP) encounter

Study Locations (1)

Michigan

  • Beaumont Health System - Royal Oak

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2024-04-25
Est. Completion 2025-06-27
Phase NA

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT06074237

The ClinicalTrials.gov registry entry for NCT06074237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,295-participant average among 5 other Vaccine Refusal trials with a reported enrollment target (91% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Vaccine Refusal appearing as the primary indexed condition, and to 2 interventions - of which Immersive resident education is the first listed.

NCT06074237 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06074237 about?

NCT06074237 is a clinical study titled "Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters". Unfortunately, only 40% of US pediatric residency programs reported in a survey that vaccine safety and counseling training is provided to residents. The success of a residency curriculum focused on communication strategies with patients hesitant to receive the influenza vaccine has been demonstrate...

What is the current status of trial NCT06074237?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2024-04-25. Estimated completion is 2025-06-27.

What conditions does trial NCT06074237 study?

This clinical trial studies the following conditions: Vaccine Refusal, Physician-Patient Relations, Vaccine-Preventable Diseases.

What interventions are being tested in trial NCT06074237?

The interventions under investigation include: Immersive resident education (OTHER), Standardized patient (SP) encounter (OTHER).

Who is sponsoring clinical trial NCT06074237?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074237 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaccine Refusal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.